Clinical Trials Directory

Trials / Unknown

UnknownNCT04778943

Oblique Lateral Interbody Fusion Versus Minimally Invasive Transforaminal Lumbar Interbody Fusion

Oblique Lateral Interbody Fusion Versus Minimally Invasive Transforaminal Lumbar Interbody Fusion for Lumbar Spinal Stenosis

Status
Unknown
Phase
Study type
Observational
Enrollment
130 (estimated)
Sponsor
Tang-Du Hospital · Academic / Other
Sex
All
Age
50 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The investigators will retrospectively study lumbar spinal stenosis patients who underwent OLIF or MIS-TLIF with percutaneous pedicle screw fixation between January 2016 and December 2019.The investigators will measure estimated blood loss, operative time, hospital stay, cost, reoperation, and complication incidence, visual analogue scale (VAS), Oswestry Disability Index (ODI), Japanese Orthopaedic Association (JOA), and Short Form-36 (SF-36) scores, discal and foraminal height, lumbar lordotic angle, and fusion status.The investigators will conduct to evaluate postoperative improvements, complications, and reoperation rates between patients with lumbar spinal stenosis (LSS) undergoing oblique lateral interbody fusion (OLIF) or minimally invasive transforaminal lumbar interbody fusion (MIS-TLIF).

Conditions

Interventions

TypeNameDescription
OTHERSurgery(OLIF and MIS-TLIF)oblique lateral interbody fusion (OLIF); minimally invasive transforaminal lumbar interbody fusion (MIS-TLIF)

Timeline

Start date
2021-02-28
Primary completion
2021-03-25
Completion
2021-03-29
First posted
2021-03-03
Last updated
2021-03-03

Source: ClinicalTrials.gov record NCT04778943. Inclusion in this directory is not an endorsement.